Location: Certara UK OfficesLevel 2-Acero1 Concourse WaySheffieldUnited Kingdom Online registration is available until: 6/29/2024 The workshop is neither trying to provide a 101 course on LCMS proteomics nor attempts to focus on what is new in LC-MS proteomics techniques. Attendees need to have some background but not necessarily leading experts in the field.
https://www.certara.com/live-events/issx-workshop-on-quantitative-lc-ms-ms-proteomics/On-site Workshop Overview Regulatory approval procedures are becoming increasingly stringent and time-consuming. Not having the right regulatory strategy in place will cost time and money, and may result in the failure or delay of your drug development program. It relayed to potential of Generative AI how it can help overcome those regulatory challenges. The emergence … Continued
https://www.certara.com/live-events/certara-regulatory-workshop-in-korea/Agenda features discussion of life sciences industry trends, business value of model-informed drug development strategies, and impact of generative AI on biosimulation and regulatory sciences RADNOR, PA– April. 18, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will host the first-ever Certainty Conference. At this event, … Continued
https://www.certara.com/announcement/certara-announces-inaugural-client-conference-with-keynote-by-dr-scott-gottlieb/New therapeutics development in rare diseases presents both opportunities and complexities. Because of the small patient pool available in these indications, there are challenges in designing and conducting clinical trials and the data interpretation that follows, and the ultimate path to registration. The top 3 critical downfalls in rare diseases development include Poor understanding of … Continued
https://www.certara.com/white-paper/the-challenges-and-opportunities-of-rare-disease-drug-development/Build Validated Studies Up To 85% Faster: With Pinnacle 21 See how to achieve faster drug development, with less effort, and less manual work. The Pinnacle 21 software suite augments your capabilities – helping you quickly build validated studies, get cleaner vendor data (minus the delays), automate SDTM, and speed time-to-analysis. Powered by technology, you’ll … Continued
https://www.certara.com/pinnacle-21-enterprise-software/demo/PRINCETON, NJ – April 16, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their licensed software, linking predictive solutions to … Continued
https://www.certara.com/pressrelease/certara-launches-cloud-platform-to-further-unify-its-end-to-end-scientific-software-platform/New, spacious location in Radnor, Pennsylvania will support the needs of company’s growing workforce and business, strengthen presence in the state RADNOR, PA – April 15, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the relocation of its corporate headquarters to Radnor, Pennsylvania. The new headquarters is 13 … Continued
https://www.certara.com/announcement/certara-announces-new-corporate-headquarters/Learn about biosimilars, their benefits for patients who take biologic drugs, and how pharmaceutical companies demonstrate their bioequivalence to approved biosimilars.
https://www.certara.com/blog/what-are-biosimilars-how-are-they-developed/